SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Weekly Update: May 23, 2022
Black Swan Connection Newsletter Signup
Breaking News
Not much joy in the markets. After seven straight weeks of losses, it’s pretty clear we are headed into a recession. The stock markets are one of the most accurate leading economic indicators, and no reason to believe this will be any different. Better keep your powder dry for now.
On a regulatory note, the SEC got their hands slapped big time last week.
This behemoth regulator that has been riding roughshod over the industry participants all in the name of protecting investors, which is hardly ever something they accomplish, has been put on notice that declaring themselves judge and jury is over.
Glowing press releases about how they extracted fines and orders barring people from the finance industry (without anyone admitting or denying guilt) are a mainstream practice aimed at the media and congress when they circle the wagons asking for more funding. Unless you’re a Goldman Sacks or JP Morgan with very deep pockets chances of defending yourself against an SEC action are pretty slim. The day they issue a press release saying they are charging you, you are on a one way street to out of business and the legal profession will take whatever you’re left with until you cry for mercy and fold your tent.
Thehill.com 5-18-22
The 5th Circuit Court of Appeals on Wednesday ruled the Securities and Exchange Commission (SEC) is denying defendants their constitutional right to a jury trial by putting them in front of its own internal judges.
In a 2-1 ruling, the court ruled for George Jarkesy and Patriot28 LLC, who sued the SEC in 2011 after the agency imposed a $300,000 fine and other punishments in a securities fraud case.
Judge Jennifer Walker Elrod wrote in the majority opinion that the SEC violated the Seventh Amendment’s right to a jury trial by bringing defendants before in-house judges and allowing the agency to “act as both prosecutor and judge.”
Congress also unconstitutionally delegated power to the SEC to act as a legislative body, Elrod wrote.
“‘We the People’ are the fountainhead of all government power. Through the Constitution, the people delegated some of that power to the federal government so that it would protect rights and promote the common good,” Elrod said. “But that accountability evaporates if a person or entity other than Congress exercises legislative power.”
One can only wonder how many cases will now be retried and allowed to be brought before a jury.
I’m for draining the swamp and cutting their budget substantially.
Corporate News
Sponsored by:
The 21st Century Investment Bank Capital Raises + Strategic Advisory
Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.
Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.
For more information go to: www.DonaldCapital-NY.com
The Premier Operating System for Publicly Traded Companies
Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.
Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.
Click Here For a Sequire Power Point Presentation
To schedule a demo email me at cdilley@smm.global or call 727-459-7378
Welcome a new player in the beverage industry !!
I just got my first samples of DINO last week and it is outstanding
4-12-2022 International Food and Beverage (OTC IFBC)
Plainview, New York–(Newsfile Corp. – April 12, 2022) – Italian Food & Beverage Corp. (OTC PINK: IFBC) last year revenue closed with a solid 30% sales increase compared to the previous year, the Company in the first quarter of this year has launched its Energy Drink in Italy through its recently acquired European Division, located by the Capital in the Region of Lazio.
The Company has garnered 2 new corporate executives. Chief Marketing Officer Chris Pati – 30+ year iconic Music Business Veteran and Founder/Chairman of IndiMusic TV, Entrepreneur and media visionary. New President Alan Cohen, is an entrepreneur with expertise on building businesses and establishing possibilities on increasing sales as well as an expert in marketing and various sports venues.
Italian Launch
With the acquisition purposes, we will be able to promote the sale of the IFBC’s Energy Drink throughout Italy, with the eventual expansion into all the countries of Europe. The Dino Luzzi Energy Drink has gained traction in Italy and is on its way to international recognition. This is evidenced by the increased allocations of shelf space by foreign and domestic retailers.
Check out this video!!
https://www.youtube.com/watch?v=mxNfUwO0pt0
Plainview, New York–(Newsfile Corp. – April 12, 2022) – Italian Food & Beverage Corp. (OTC PINK: IFBC) last year revenue closed with a solid 30% sales increase compared to the previous year, the Company in the first quarter of this year has launched its Energy Drink in Italy through its recently acquired European Division, located by the Capital in the Region of Lazio.
The Company has garnered 2 new corporate executives. Chief Marketing Officer Chris Pati – 30+ year iconic Music Business Veteran and Founder/Chairman of IndiMusic TV, Entrepreneur and media visionary. New President Alan Cohen, is an entrepreneur with expertise on building businesses and establishing possibilities on increasing sales as well as an expert in marketing and various sports venues.
Italy 2022 Windsurfer Spring Cup
On April 9th and 10th of this year, this new Division sponsored the Windsurfer Spring Cup National Regatta, the venue for which is historic Anzio, Italy. Throughout this Regatta, the Energy Drink was promoted extensively, in particular, on the beach of Anzio with young, lively, attractive company representatives presenting the product as it is, and in a new line of specifically formulated cocktails.
This promotional effort was further enhanced by way of a festival-like atmosphere, which was generated by the presence of many great food stands, restaurants, shops, children’s and family entertainment venues at a nearby shopping center. At the center of it all, and resting atop a specially constructed cupola, was a 3-meter tall, brightly illuminated Dino Luzzi Energy Drink, which was clearly visible to tourists and locals alike, from the Ciampino Rome airport, and will remain accessible to the local community for the entire summer.
Read the Complete Press Release
05-18-2021 CanB Corp (OTC CANB)
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY, May 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company’s financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
- Revenue increased 606% to $1.9 million
- Gross profit increased 291% to $0.7 million
- Adjusted EBITDA loss decreased 30% to $0.9 million
- Total assets increased to $17.0 million
- Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
- Solidified and integrated vertical processing capabilities from recent acquisitions
- Advanced build-out of first CBD lounge in Miami, Florida
- Continuing path for potential NASDAQ up-listing
5-17-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
WEXFORD, Pa., May 17, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Terms of the deal were not disclosed.
The exclusive option agreement involves the intellectual property rights to three technologies jointly developed in the laboratories of Jason Lohmueller, Ph.D., Assistant Professor of Immunology; Alexander Deiters, Ph.D., Professor of Chemistry; and Olivera Finn, Ph.D., Professor of Immunology: 1) mSA2 affinity-enhanced biotin-binding CAR, 2) universal self-labeling SynNotch and CARs for programable antigen-targeting, and 3) conditional control of universal CAR-T cells through stimulus-reactive adaptors. Per the option agreement, Coeptis paid the University of Pittsburgh a non-refundable fee for the exclusive option to license the patent rights to each of the three technologies. Coeptis has until October 29, 2022, to exercise the options and pay the specified exercise considerations. The option agreement may be extended an additional six months, subject to the agreement of both parties.
5-10-2022 SRAX (NASDAQ: SRAX)
NSAV Announces Partnership with SRAX to Enhance Investor Communications
London, England, May 10, 2022 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced that they have entered into a partnership with SRAX (NASDAQ: SRAX) to maximize and accelerate its communications for interested investors, shareholders, and supporters.
Through SRAX, a publicly traded company offering premier operating system tools for publicly traded companies, NSAV will have the ability to further reach its community through sophisticated solutions to assist it in maintaining, communicating, and expanding its shareholder base.
5-2-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF)
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary
– $6.5 million all-cash transaction, including milestone payments
– Enables exclusive focus on drug pipeline
TORONTO, May 02, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian full-service distributor of pharmaceuticals and medical devices to dental professionals.
4-19-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
Transaction expected to accelerate Coeptis’ ability to progress its innovative cell therapy platforms for cancer
David Mehalick of Coeptis to serve as Chief Executive Officer;
Chris Calise of Bull Horn to join the Board of Directors
Merger anticipated to close in third quarter 2022; combined company anticipated to list on Nasdaq
WEXFORD, Pa., and MIAMI, Fla., April 19, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, and Bull Horn Holdings Corp. (Nasdaq: BHSE) (“Bull Horn”), a special purpose acquisition company (SPAC), today announced they have entered into a definitive merger agreement for a business combination that will result in Coeptis becoming a wholly-owned subsidiary of Bull Horn. Under the terms of the merger agreement, a wholly-owned subsidiary of Bull Horn will merge with and into Coeptis and the holders of the outstanding Coeptis shares will receive equity in Bull Horn valued at $175 million (subject to adjustments).
04-13-2022 Coeptis Therapeutics, Inc. OTC COEP
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to enter into a strategic agreement with Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, to sell Statera’s rights to Entolimod and other related toll-like receptor 5 (TLR5) agonists. The consummation of the transaction is contingent upon negotiation of a definitive agreement and satisfaction of a number of closing conditions, including a contingency on Coeptis financing.
3-30-2022 SRAX (NASDAQ: SRAX)
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
LD Micro is host to the most influential conferences in the small and microcap world. Chris Lahiji, founder of the prestigious function, notes the success of the Main Event last October as a “great success that restored humanity within our industry. People could finally see each other and connect again in person. As a result, the upcoming Invitational was the fastest sell-out in our history.”
New on the Scene is Ecrid, Inc. taking on the establishment with a new and improved credit reporting system.
Check it out!!
10-15 2021 Ecrid, Inc (OTC ECDD)
ECRID, the New Credit Bureau Files New IPO
STUART, Fla. , Oct. 15, 2021 /PRNewswire/ — ECRID (OTC: ECDD) is the New Credit Bureau ( www.ECRID.com ) that offers each member the opportunity to create their own personal ECRID Credit Report with conventional and unconventional creditors that they have paid on time to validate their credit worthiness (rental payments included) to lenders. Each Credit Report Holder starts out with a Perfect 950 Credit Score.
An ECRID executive said, “We’re extremely excited and thrilled to prepare to launch one of the most exciting and novel Fintech Credit Lending platforms of its kind, at a time where a large percentage of adults have cash flow, but unfortunately deemed to have poor credit scores.”
First, ECRID Bill Pay Service is second to none. ECRID Credit Report Holders will pay their monthly bills listed on their ECRID Credit Report, through an automated ECRID Electronic Payment System. Once payment is processed, the ECRID Credit Score and payment status will update in real time on the ECRID User’s Credit Report. This process and method gives Lenders validation on how each ECRID Credit Report Holder pays their bills. Secondly, ECRID Credit Report Holders will be able to apply for loans (Home, Auto & Personal loans) inside their ECRID Business Center. Lenders will have access to sign up at www.ECRID.com to become a member and offer their services to the ECRID Credit Report Holders who are looking for financing. The goal is to start offering lending services in November 2021 . ECRID Lenders will be asked not to pull an Equifax, Experion, or Transunion credit report, but instead, base their Novel Fintech Sector Lending on the actual individual user’s ECRID Credit Report. This will give the ECRID User (borrower) a fresh start and a second chance at reestablishing themselves as credit-worthy borrowers. The company’s (ECRID) primary objective is to base the lending decision on the user’s (borrower) ECRID Credit Report along with the user’s (borrower) income-to-debt ratio.
03-07-2021 CanB Corp (OTC CANB)
Greenridge Global Research update
Up To 100 CBD Lab Lounges To Be Launched
Up To 100 CBD Lab Lounges To Be Launched. Yesterday, the Company announced a ten-year deal with American Development Partners (“ADP”) to finance and develop up to 100 CBD Lounges, similar to CANB’s Lab2 format at its Miami facility. The Lab2 concept, which is nearing completion, features a bar/lounge consumption area with viewing windows to see products, like gummies and gelato, being made. The ADP-developed lounges are expected to be similar, having a bar/lounge space with viewing windows to see various end products being produced. The lounges will serve CANB as a relatively cheap way to establish regional production and distribution, enable it to build its brands on a national level, engage in a wider range of product R&D, and increase branded product sales in the lounges. ADP has budgeted $4 million for each lounge (committing $200 million with an option for another $200 million), and will receive a 10% development fee and a 20-year lease on each lounge from CANB. No additional details were released, other than the Company noting no equity was involved in the deal. ADP has a history of real estate development projects, with clients ranging from Wendy’s, Subway, Hampton Inn, Gold’s Gym, and AutoZone, among many other nationwide chains.
Alternative Investments
Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama
3700 Acre Private Island in the Las Perlas Islands
7.4 Acre beachfront paradise for development or private retreat
Message me on Linkedin and check our latest commercial listings:
https://www.linkedin.com/in/carldilley/
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
Black Swan Connection Newsletter Signup
| May 23, 2022 COMPANY QUOTES, LISTINGS RESEARCH AND NEWS Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD) Profile Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News Can B Corp (CANB) Profile News Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News Social Reality, Inc. (SRAX) Profile News International Food and Beverage |
ValuEngine Weekly Report
Navigating the Volatility Vortex – How Well Have Safe Harbor ETFs Performed?
May 18, 2022 by Herb Blank
In the past January Year-End review, I noted that ValuEngine models were predicting a down market for 2022. In March, as fears of interest rate hikes, continued runaway inflation and global implications of the Russian invasion played on investors’ minds, I wrote a column specifically on potential safe harbors in the wake of the perfect storm. I recommended that concerned investors, especially those near or in retirement, consider moving about 30% of their current core equity exposure to less volatile options. This should allow them to better weather a potential storm without bailing out altogether.
Read Complete Report
ValuEngine new strategies, Podcast introduction
ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.
VIEW JORDAN’S INTRODUCTORY PODCAST HERE
on www.ValuEngine.com
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE
Black Swan Research Coverage and Subscription Service
Click Here>>
Event Calendar Updates
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
For more information on LD Micro, visit ldmicro.com.
Rocky Mountain Microcap Conference IX.
Event will be held May 25, 2022 conference at TopGolf in Centennial Colorado
As with past conferences, Rocky Mountain Microcap Conference IX will be a single-track, single day, 13 company event. Each presenter will be allotted 25-minutes and we expect the conference to run from approximately 10 am until 5:30 pm followed by drinks, dinner and golf. Lunch will be served as well. Unlike, like our past few events, this conference we will be an in-person event only as we will not be providing a virtual option.
dave@trickleresearch.com
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
Distribution (Reach)
SMM Global Twitter Acct (Impressions last 30 days) 520
SMM Global Facebook Page (Reach last-30 days) 6,462
SMM Linkedin Pages (contacts) 1,100
SMM Youtube Channel (followers) 6
SMM Instagram Page * (followers) 11
Direct Email * 220,000
Total 256,460